Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Thomas

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Blood|July 21, 2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemiaHardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher, et al.
Bone Marrow Transplantation|November 24, 2022
Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experiencePeter Dreger, Udo Holtick, Marion Subklewe, et al.
Haematologica|January 18, 2024
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cellsKathrin Hammon, Kathrin Renner, Michael Althammer, et al.
Brain : a Journal of Neurology|June 25, 2024
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestationsGage P Kosmanopoulos, Jack K Donohue, Maya Hoke, et al.
Brain : a Journal of Neurology|July 18, 2024
Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variantsSarah H Berth, Linh Vo, Do Hoon Kwon, et al.
Blood|March 22, 2022
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in GermanyWolfgang A Bethge, Peter Martus, Michael Schmitt, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Blood|July 21, 2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemiaHardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher, et al.
Bone Marrow Transplantation|November 24, 2022
Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experiencePeter Dreger, Udo Holtick, Marion Subklewe, et al.
Haematologica|January 18, 2024
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cellsKathrin Hammon, Kathrin Renner, Michael Althammer, et al.
Brain : a Journal of Neurology|June 25, 2024
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestationsGage P Kosmanopoulos, Jack K Donohue, Maya Hoke, et al.
Brain : a Journal of Neurology|July 18, 2024
Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variantsSarah H Berth, Linh Vo, Do Hoon Kwon, et al.
Blood|March 22, 2022
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in GermanyWolfgang A Bethge, Peter Martus, Michael Schmitt, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 7